Hualan Biological Bacterin Inc. (301207.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.08B |
| Enterprise Value | 10.74B |
| P/E Ratio | 55.62 |
| PEG Ratio | -9.46 |
| Price/Sales Ratio | 8.73 |
| Price/Book Ratio | 1.83 |
| Enterprise/Revenue | 8.42 |
| Enterprise/EBITDA | 33.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 1.2B |
| Revenue/Share | 2.03 |
| Gross Profit | 893.76M |
| EBITDA | 331.64M |
| Net Income | 182.92M |
| Diluted EPS | 0.31 |
Balance Sheet
| Total Cash | 2.56B |
| Total Cash/Share | 4.31 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.15 |
| Book Value Per Share | 9.65 |
Price History
| 52-Week Change | -7.44 |
| 52-Week High | 27.88 |
| 52-Week Low | 15.43 |
| Moving Average 50 Days | 17.13 |
| Moving Average 200 Days | 19.72 |
Statistics
| Average Volume | 7.13M |
| Shares Outstanding | 595M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.4 |
| Trailing Annual Dividend Yield | 7.92 |
| Payout Ratio | 2.55 |
| Last Split Factor | 3:2 |
| Last Split Date | June 07, 2023 |
AD
